TRACON Pharmaceuticals Email Format

Biotechnology ResearchUnited States2-10 Employees

TRACON Pharmaceuticals is a United States-based biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer. It operates a cost-efficient product development platform that does not rely on a traditional CRO model, enabling partnerships with non-U.S. companies to develop and commercialize products in the United States. The company serves as a conduit between foreign developers and the U.S. market, coordinating development efforts to advance targeted cancer therapies.

Its client base comprises ex-U.S. biotechnology developers seeking U.S. development and commercialization support for their cancer therapies. The organization is described as a small team within the biotechnology research sector. A 2024 development notes that TRACON is actively developing Envafolimab in the United States.

Sign up for free to view info

Company overview Employee directory